Max Healthcare Institute Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors also approved a capital expenditure of approximately ₹425 Crore for the expansion of its Super Speciality Hospital in Vaishali, which will add ~250 beds. The company also reported appointments and a resignation in its senior management team.
Max Healthcare Board Meeting Highlights
Max Healthcare Institute Limited held a Board meeting on August 13, 2026, where several key decisions were made, including the approval of its financial results and a significant capital expenditure plan. The company is committed to expanding its healthcare infrastructure to meet growing demand.
Financial Performance for Q1 FY27
The unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved. The company reported a profit for the period of ₹32,296 lakhs (consolidated) and ₹16,760 lakhs (standalone). Revenue from operations stood at ₹2,36,617 lakhs (consolidated) and ₹78,292 lakhs (standalone) for the quarter.
Expansion of Max Super Speciality Hospital, Vaishali
A significant capital expenditure of approximately ₹425 Crore has been approved for the expansion of the Max Super Speciality Hospital in Vaishali. This expansion involves constructing an additional hospital block, ‘Tower 3’, which will add approximately 202 census beds and 48 non-census beds to the existing capacity of about 387 beds. The project is expected to be commissioned by November 2029 and will be financed through a combination of internal accruals and borrowings. This expansion aims to cater to the healthcare needs of the communities in and around the Ghaziabad region.
Senior Management Changes
The Board also approved changes within its Senior Management Personnel. Mr. Ajay Vij has been appointed as Director – Chief Supply Chain & Procurement Officer, effective August 14, 2026. Mr. Pawan Kumar Marella has been appointed as Senior Director – Chief Experience & Brand Officer, effective August 17, 2026. In a separate development, Dr. N. Venkatesan, Senior Director & Chief Procurement Officer, has resigned and will cease to be a Senior Management Personnel of the Company effective August 31, 2026, to pursue future career opportunities.
In-Principle Approval for Medical Colleges
The Board has given its in-principle approval to explore and evaluate the establishment of medical colleges and medical institutions, either directly or through subsidiaries. This initiative is in response to proposed amendments by the National Medical Commission (NMC) that would allow companies incorporated under the Companies Act, 2013, to pursue such activities. Concurrently, the Company’s Memorandum of Association will be amended to incorporate additional enabling objects aligned with its long-term business strategy.
Meeting Details
The Board meeting commenced at 11:48 AM IST and concluded at 2:19 PM IST. The disclosure will also be hosted on the company’s website, www.maxhealthcare.in.
Source: BSE
